Venipuncture for Lead Screening (Rhode Island mandated)
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Defines coverage and reimbursement for venipuncture (and capillary collection) for blood lead testing for children under age 6 as required by Rhode Island law; applies to commercial products and references state-mandated benefits.
No material clinical or coverage changes in this revision.
Coverage Criteria
Covered services — RI-mandated lead screening
Covered when ALL of the following are met
Applies per department regulations; department of human services or department of health will pay when patient is eligible for medical assistance or not covered by any health insurance.
Covered procedure codes: 36415-32 (venous venipuncture) and 36416-32 (capillary collection).
Supplemental policies that only provide coverage for specific diseases, hospital indemnity, Medicare supplements, or other supplemental policies are excluded from the Rhode Island mandate's reimbursement requirement. This policy follows Rhode Island General Law § 23-24.6-9, which requires screening for lead poisoning and related diagnostic evaluations for children under six to be covered and reimbursable under general accident or health insurance policies, but explicitly exempts the listed supplemental policy types from that requirement.
This policy does not specify any medical necessity criteria; medical criteria are noted as not applicable.
Coding
Provider Actions & Billing
No step therapy required
This policy specifies no medical necessity criteria or step therapy requirements for lead screening blood collection.
- No step edits or prerequisite treatments/tests are required by this policy for venipuncture or capillary lead testing.
Billing and documentation guidance
Submit claims for venipuncture or capillary blood collection for lead testing with the appropriate -32 modifier and include supporting documentation; verify member-specific benefits via the provider call center or subscriber agreement.
Benefit variability can trigger denial
Benefits may vary between groups/contracts; if the member's Benefit Booklet, Evidence of Coverage, or Subscriber Agreement does not include physician services or lab coverage for this service, the claim may be denied.
- Check the member's contract documents before providing services to avoid potential denial.
- If services are non-covered, obtain the member's written agreement before charging them.
Background
Lead is a toxic heavy metal that is particularly harmful to young children. Before 1978 lead was commonly used in paint and other products; exposure can occur when children ingest or inhale lead-containing dust or contaminated soil. In children under six years of age, lead exposure is associated with developmental delays, cognitive deficits, and behavioral problems even at low blood lead levels. Rhode Island law (§ 23-24.6-9) recognizes the high risk to this age group and requires coverage and reimbursement for screening and diagnostic evaluations, including confirmatory blood lead testing, for children under six.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.